Rapport Therapeutics, Inc.: insider trading
139 trades by 15 directors, officers and 10% owners since 2024, from their SEC Form 4 and 5 filings.
Bought, 12 months
$22.0 M
11 purchases by 7 insiders
Sold, 12 months
$46.7 M
66 sales by 6 insiders
Bought, 3 months
$22.0 M
11 purchases
Sold, 3 months
$4.5 M
14 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (15)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Third Rock Ventures V, L.P.Director, 10% owner | 6.52 M | — | $6.1 M | |
| James HealyDirector | — | $20.4 M | — | |
| Ramiro SanchezDirector | 3,600 | $98 K | — | |
| John MaraganoreDirector | — | $249 K | — | |
| Paul M. SilvaDirector | — | $100 K | — | |
| Steven M. PaulDirector | — | $974 K | — | |
| Wendy B. YoungDirector | 13,289 | $100 K | — | |
| Abraham CeesayChief Executive Officer, Director | 450,035 | — | $5.7 M | |
| Troy A. IgnelziChief Financial Officer | 15,500 | $144 K | — | |
| Cheryl GaultChief Operating Officer | 139,914 | — | $1.2 M | |
| Krishnaswamy YeleswaramChief Development Officer | 195,862 | — | $4.5 M | |
| Third Rock Ventures VI, L.P.10% owner | 6.43 M | — | $28.3 M | |
| David BredtChief Scientific Officer | 393,075 | — | $927 K | |
| Reid M. HuberDirector | 20,400 | — | — | |
| Robert Nelsen10% owner | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | James HealyDirector | Buyindirect | +952,380 | $21.00 | $20.0 M | 2.82 M | Form 4 |
| filed | James HealyDirector | Buyindirect | +6,395 | $21.00 | $134 K | 17,990 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,772 | $21.00 | $79 K | 14,924 | Form 4 |
| filed | James HealyDirector | Buyindirect | +6,933 | $21.00 | $146 K | 25,267 | Form 4 |
| filed | Ramiro SanchezDirector | Buy | +3,600 | $27.35 | $98 K | 3,600 | Form 4 |
| filed | Wendy B. YoungDirector | Buy | +3,789 | $26.39 | $100 K | 13,289 | Form 4 |
| filed | John MaraganoreDirector | Buyindirect | +8,239 | $26.38 | $217 K | 8,239 | Form 4 |
| filed | Steven M. PaulDirector | Buyindirect | +35,714 | $27.28 | $974 K | 77,380 | Form 4 |
| filed | Paul M. SilvaDirector | Buyindirect | +3,680 | $27.07 | $100 K | 3,680 | Form 4 |
| filed | John MaraganoreDirector | Buyindirect | +1,172 | $26.92 | $32 K | 9,411 | Form 4 |
| filed | Troy A. IgnelziChief Financial Officer | Buy | +5,500 | $26.10 | $144 K | 15,500 | Form 4 |
| filed | Steven M. PaulDirector | Buyindirect | +28,284 | $24.50 | $693 K | 28,284 | Form 4 |
| filed | Reid M. HuberDirector | Buy | +20,400 | $24.48 | $499 K | 20,400 | Form 4 |
| filed | Steven M. PaulDirector | Buyindirect | +13,382 | $24.97 | $334 K | 41,666 | Form 4 |
| filed | Wendy B. YoungDirector | Buy | +3,500 | $22.60 | $79 K | 9,500 | Form 4 |
| filed | Troy A. IgnelziChief Financial Officer | Buy | +100 | $9.980 | $998 | 10,000 | Form 4 |
| filed | Troy A. IgnelziChief Financial Officer | Buy | +9,900 | $10.10 | $100 K | 9,900 | Form 4 |
| filed | Wendy B. YoungDirector | Buy | +6,000 | $10.21 | $61 K | 6,000 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,538 | $23.08 | $82 K | 28,993 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,565 | $24.21 | $86 K | 32,558 | Form 4 |
| filed | James HealyDirector | Buyindirect | +4,544 | $25.02 | $114 K | 37,102 | Form 4 |
| filed | James HealyDirector | Buyindirect | +2,559 | $26.06 | $67 K | 39,661 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,799 | $23.08 | $88 K | 21,660 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,828 | $24.21 | $93 K | 25,488 | Form 4 |
| filed | James HealyDirector | Buyindirect | +4,878 | $25.02 | $122 K | 30,366 | Form 4 |
| filed | James HealyDirector | Buyindirect | +2,748 | $26.06 | $72 K | 33,114 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,630 | $23.08 | $84 K | 29,908 | Form 4 |
| filed | James HealyDirector | Buyindirect | +3,657 | $24.21 | $89 K | 33,565 | Form 4 |
| filed | James HealyDirector | Buyindirect | +4,661 | $25.02 | $117 K | 38,226 | Form 4 |
| filed | James HealyDirector | Buyindirect | +2,625 | $26.06 | $68 K | 40,851 | Form 4 |
| filed | James HealyDirector | Buyindirect | +470,589 | $17.00 | $8.0 M | 1.86 M | Form 4 |
| filed | James HealyDirector | Buyindirect | +18,641 | $17.00 | $317 K | 18,641 | Form 4 |
| filed | James HealyDirector | Buyindirect | +17,861 | $17.00 | $304 K | 17,861 | Form 4 |
| filed | James HealyDirector | Buyindirect | +26,278 | $17.00 | $447 K | 26,278 | Form 4 |
| filed | James HealyDirector | Buyindirect | +25,455 | $17.00 | $433 K | 25,455 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice